查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1631212

兽医肿瘤学市场规模、份额、趋势分析报告：按动物类型、治疗方法、癌症类型、地区、细分市场预测，2025-2030 年

Veterinary Oncology Market Size, Share & Trends Analysis Report By Animal Type (Canine, Feline), By Therapy (Radiotherapy, Surgery), By Cancer Type, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

兽医肿瘤学市场成长与趋势：

预计2030年全球兽医肿瘤市场规模将达31.1亿美元，2025年至2030年复合年增长率预计为12.08%。

宠物癌症盛行率的增加和对兽医诊断的需求预计将在预测期内推动市场发展。

全球采用犬癌症登记处来估计癌症发生率是市场成长的另一个驱动因素。根据2019年2月《兽医科学前沿》报道，瑞士犬癌症登记处（SCCR）被用作资料来源并进行彙编，以供未来犬类和人类癌症的比较研究。该资料库进一步有助于减少人群中恶性肿瘤的发生，从而促进市场成长。

进行兽医肿瘤学研究的研究人员正在进一步推动兽医肿瘤学市场的成长。例如，2017 年 8 月，伊利诺大学进行了一项研究，旨在更准确地检测狗的头颈部肿瘤转移（癌症在体内的扩散）。此外，市场公司也专注于新产品创新和策略联盟。例如，2018 年，Oasmia Pharmaceutical AB 的子公司 AdvaVet 开发了基于奈米颗粒配方的 XR17 技术，该技术使单一活性药物成分 (API) 或多种 API 水溶性。这是联合治疗，也是许多宠物癌症疾病的标准治疗方法。

兽医肿瘤学市场报告亮点

  • 伴同性动物癌症盛行率的不断上升、评估宠物癌症治疗的安全性和有效性的多项临床试验研究以及兽医癌症治疗的技术进步正在推动市场成长，预计将创造机会。
  • 化疗在未来几年中占据了最大的收益占有率，因为它越来越多地用于宠物的癌症治疗，无论是单独使用还是与其他治疗方法结合使用。
  • 到2024年，狗的收益占有率最大，超过86.09%，狗的数量不断增加，而且与猫相比，狗的癌症患病率更高。
  • 截至 2024 年，北美占据压倒性份额。这是由于有利的政府政策、公司新产品的推出以及对兽医癌症治疗的巨额投资。
  • 由于对动物健康和支出的日益关注、患有癌症的宠物数量的增加、政府对动物安全的关注以及遏制宠物癌症病例的多项倡议，亚太地区正在迅速增长，预计将呈现良好的增长。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章 兽医肿瘤市场的波动趋势与范围

  • 市场体系展望
    • 母市场
    • 辅助市场
  • 市场动态
    • 市场成长要素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 兽医肿瘤学市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • 法律规范
    • 主要国家和主要物种的动物数量估计（2018-2023）
    • 产品价格分析
    • COVID-19 影响分析

第四章兽医肿瘤学市场：按动物类型的估计和趋势分析

  • 细分仪表板
  • 兽医肿瘤学市场：按动物类型的波动分析
  • 按动物类型分類的兽医肿瘤学市场规模和趋势分析（2018-2030）
    • 狗
    • 猫
    • 马

第五章兽医肿瘤学市场：依治疗方法进行估计与趋势分析

  • 细分仪表板
  • 兽医肿瘤学市场：治疗方法波动分析
  • 兽医肿瘤学市场规模与趋势分析：依治疗方法分类（2018-2030）
    • 放射治疗
    • 外科手术
    • 化疗
    • 免疫疗法
    • 其他治疗方法

第六章兽医肿瘤学市场：按癌症类型分類的估计和趋势分析

  • 细分仪表板
  • 兽医肿瘤学市场：按癌症类型分類的波动分析
  • 兽医肿瘤学市场规模和趋势分析：按癌症类型（2018-2030）
    • 皮肤癌
    • 淋巴瘤
    • 肉瘤
    • 其他的

第七章兽医肿瘤学市场：按动物类型、治疗方法和癌症类型进行的国家估计和趋势分析

  • 区域仪表板
  • 兽医肿瘤学市场占有率：按地区（2023/2030）
  • 区域展望
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 市场参与企业分类
  • 市场公司概况
  • 财务表现
  • 产品基准
  • 2023年市场情势分析（热图分析）
  • 策略规划
    • 併购
    • 发射
    • 伙伴关係与协作
    • 扩张
    • 其他的
  • 公司简介
    • Elanco
    • Boehringer Ingelheim International GmbH
    • Zoetis
    • Elekta AB
    • PetCure Oncology
    • Accuray Incorporated
    • Varian Medical Systems, Inc.（parent company：Siemens Healthineers）
    • Virbac
    • Merck &Co., Inc.
    • Dechra Pharmaceuticals PLC
    • NovaVive Inc.
    • Ardent Animal Health, LLC（A BreakthrU Company）
Product Code: GVR-4-68038-182-5

Veterinary Oncology Market Growth & Trends:

The global veterinary oncology market size is expected to reach USD 3.11 billion in 2030 and is projected to grow at a CAGR of 12.08% from 2025 to 2030. Increasing prevalence of cancer in pets and demand for veterinary diagnostics are projected to drive the market over the forecast period.

Adoption of canine cancer registry globally to estimate cancer incidences is another driving factor for the market growth. According to frontiers in Veterinary Science in February 2019, the Swiss Canine Cancer Registry (SCCR) was used as a data source and was compiled for future comparative studies of canine and human cancers. This database is further helpful in mitigating the incidence of malignant tumors in the human population, thereby driving the market growth.

Researchers carrying out studies focused on veterinary oncology are further boosting the veterinary oncology market growth. For instance, University of Illinois in August 2017, carried out study that involves more precise detection of metastasis (spread of cancer through the body) for head and neck tumors in dogs. Moreover, the market players are also focusing on new product innovation and strategic collaborations. For instance, in 2018 AdvaVet, a subsidiary of Oasmia Pharmaceutical AB, developed XR17 technology, which is nanoparticle formulation based that makes a single Active Pharmaceutical Ingredient (API) or multiple APIs water soluble. It is a combination therapy and is also a standard treatment for a number of cancer diseases in pet animals.

Veterinary Oncology Market Report Highlights:

  • Increasing prevalence of cancer in companion animals, several clinical trial studies to evaluate the safety and effectiveness of cancer therapeutics for pets and technological advancements in veterinary oncology treatment are anticipated to create growth opportunities in the market.
  • Chemotherapy accounted for the largest revenue share over the coming years, owing to its increasing adoption for pet cancer treatment either alone or in combination with other therapies.
  • The canine segment held the largest revenue share of over 86.09% in 2024, increasing the population of dogs and high prevalence of cancer in dogs as compared to cats.
  • North America held the dominant share as of 2024, due to the favorable government policies, new product launch by the companies, and huge investment for veterinary oncology treatment.
  • Asia Pacific is anticipated to witness lucrative growth due to increasing focus on animal health and expenditure, increasing number of pet population being exposed to cancer, government focus on animal safety, and several initiatives to curb cancer cases in pet animals.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
    • 1.7.2. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Veterinary Oncology Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market
    • 3.1.2. Ancillary Market
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of cancer in pets
      • 3.2.1.2. Increasing R&D in pet cancer therapy
      • 3.2.1.3. Growing focus on animal safety
      • 3.2.1.4. Growing uptake of pet insurance
      • 3.2.1.5. Technological advancements in pet cancer treatment
      • 3.2.1.6. Increase in pet population
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of treatment
      • 3.2.2.2. Adverse effects associated with therapies
      • 3.2.2.3. Limited clinical evidence
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Veterinary Oncology Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitution
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental Landscape
    • 3.3.3. Regulatory Framework
    • 3.3.4. Estimated Animal Population, by Key Countries and Key Species, 2018-2023
    • 3.3.5. Product Pricing Analysis
    • 3.3.6. COVID-19 Impact Analysis

Chapter 4. Veterinary Oncology Market: Animal Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Veterinary Oncology Market Product Movement Analysis
  • 4.3. Veterinary Oncology Market Size & Trend Analysis, By Animal Type, 2018 - 2030 (USD Million)
    • 4.3.1. Canine
      • 4.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.2. Feline
      • 4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.3.3. Equine
      • 4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Veterinary Oncology Market: Therapy Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Veterinary Oncology Market Application Movement Analysis
  • 5.3. Veterinary Oncology Market Size & Trend Analysis, By Therapy, 2018 - 2030 (USD Million)
    • 5.3.1. Radiotherapy
      • 5.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.3.1.2. Stereotactic Radiation Therapy
        • 5.3.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
        • 5.3.1.2.2. LINAC
          • 5.3.1.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
        • 5.3.1.2.3. Other Types
          • 5.3.1.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 5.3.1.3. Conventional Radiation Therapy
        • 5.3.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.2. Surgery
      • 5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.3. Chemotherapy
      • 5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.4. Immunotherapy
      • 5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.5. Other Therapies
      • 5.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Veterinary Oncology Market: Cancer Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Veterinary Oncology Market Animal Movement Analysis
  • 6.3. Veterinary Oncology Market Size & Trend Analysis, By Cancer Type, 2018 - 2030 (USD Million)
    • 6.3.1. Skin Cancers
      • 6.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.2. Lymphomas
      • 6.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.3. Sarcomas
      • 6.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.4. Others
      • 6.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Veterinary Oncology Market: Country Estimates & Trend Analysis, by animal type, therapy, & cancer type

  • 7.1. Regional Dashboard
  • 7.2. Veterinary Oncology Market Share, By Region, 2023 & 2030, USD Million
  • 7.3. Regional Outlook
  • 7.4. North America
    • 7.4.1. North America Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competition Insights
      • 7.4.2.3. U.S. Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competition Insights
      • 7.4.3.3. Canada Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competition Insights
      • 7.4.4.3. Mexico Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competition Insights
      • 7.5.2.3. UK Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competition Insights
      • 7.5.3.3. Germany Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competition Insights
      • 7.5.4.3. France Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competition Insights
      • 7.5.5.3. Italy Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competition Insights
      • 7.5.6.3. Spain Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competition Insights
      • 7.5.7.3. Denmark Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competition Insights
      • 7.5.8.3. Sweden Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competition Insights
      • 7.5.9.3. Norway Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competition Insights
      • 7.6.2.3. Japan Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competition Insights
      • 7.6.3.3. China Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competition Insights
      • 7.6.4.3. India Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competition Insights
      • 7.6.5.3. Australia Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competition Insights
      • 7.6.6.3. South Korea Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competition Insights
      • 7.6.7.3. Thailand Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competition Insights
      • 7.7.2.3. Brazil Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competition Insights
      • 7.7.3.3. Argentina Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competition Insights
      • 7.8.2.3. South Africa Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competition Insights
      • 7.8.3.3. Saudi Arabia Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competition Insights
      • 7.8.4.3. UAE Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competition Insights
      • 7.8.5.3. Kuwait Veterinary Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Participants Overview
  • 8.3. Financial Performance
  • 8.4. Product Benchmarking
  • 8.5. Market Position Analysis, 2023 (Heat Map Analysis)
  • 8.6. Strategy Mapping
    • 8.6.1. MERGERS AND ACQUISITIONS
    • 8.6.2. LAUNCH
    • 8.6.3. PARTNERSHIPS & COLLABORATIONS
    • 8.6.4. EXPANSION
    • 8.6.5. OTHERS
  • 8.7. Company Profiles
    • 8.7.1. Elanco
      • 8.7.1.1. Participant's overview
      • 8.7.1.2. Financial performance
      • 8.7.1.3. Product Benchmarking
      • 8.7.1.4. Strategic initiatives
    • 8.7.2. Boehringer Ingelheim International GmbH
      • 8.7.2.1. Participant's overview
      • 8.7.2.2. Financial performance
      • 8.7.2.3. Product Benchmarking
      • 8.7.2.4. Strategic initiatives
    • 8.7.3. Zoetis
      • 8.7.3.1. Participant's overview
      • 8.7.3.2. Financial performance
      • 8.7.3.3. Product Benchmarking
      • 8.7.3.4. Strategic initiatives
    • 8.7.4. Elekta AB
      • 8.7.4.1. Participant's overview
      • 8.7.4.2. Financial performance
      • 8.7.4.3. Product Benchmarking
      • 8.7.4.4. Strategic initiatives
    • 8.7.5. PetCure Oncology
      • 8.7.5.1. Participant's overview
      • 8.7.5.2. Financial performance
      • 8.7.5.3. Product Benchmarking
      • 8.7.5.4. Strategic initiatives
    • 8.7.6. Accuray Incorporated
      • 8.7.6.1. Participant's overview
      • 8.7.6.2. Financial performance
      • 8.7.6.3. Product Benchmarking
      • 8.7.6.4. Strategic initiatives
    • 8.7.7. Varian Medical Systems, Inc. (parent company: Siemens Healthineers)
      • 8.7.7.1. Participant's overview
      • 8.7.7.2. Financial performance
      • 8.7.7.3. Product Benchmarking
      • 8.7.7.4. Strategic initiatives
    • 8.7.8. Virbac
      • 8.7.8.1. Participant's overview
      • 8.7.8.2. Financial performance
      • 8.7.8.3. Product Benchmarking
      • 8.7.8.4. Strategic initiatives
    • 8.7.9. Merck & Co., Inc.
      • 8.7.9.1. Participant's overview
      • 8.7.9.2. Financial performance
      • 8.7.9.3. Product Benchmarking
      • 8.7.9.4. Strategic initiatives
    • 8.7.10. Dechra Pharmaceuticals PLC
      • 8.7.10.1. Participant's overview
      • 8.7.10.2. Financial performance
      • 8.7.10.3. Product Benchmarking
      • 8.7.10.4. Strategic initiatives
    • 8.7.11. NovaVive Inc.
      • 8.7.11.1. Participant's overview
      • 8.7.11.2. Financial performance
      • 8.7.11.3. Product Benchmarking
      • 8.7.11.4. Strategic initiatives
    • 8.7.12. Ardent Animal Health, LLC (A BreakthrU Company)
      • 8.7.12.1. Participant's overview
      • 8.7.12.2. Financial performance
      • 8.7.12.3. Product Benchmarking
      • 8.7.12.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Estimated cost of dog cancer treatment (2024)
  • Table 3 North America vet oncology average price by therapy category (USD, 2024)
  • Table 4 Estimated animal population by species & by country, 2018 to 2022
  • Table 5 Veterinary oncology market estimates & forecasts, by animal type, 2018 to 2030 (USD Million)
  • Table 6 Veterinary oncology market estimates & forecasts, by therapy, 2018 to 2030 (USD Million)
  • Table 7 Global radiotherapy market, by type, 2018 - 2030 (USD Million)
  • Table 8 Global stereotactic radiation therapy market, by type, 2018 - 2030 (USD Million)
  • Table 9 Veterinary oncology market estimates and forecast, by cancer type, 2018 - 2030 (USD Million)
  • Table 10 Ongoing veterinary sarcoma clinical trials at Colorado State University
  • Table 11 North America Veterinary Oncology Market, by Country, 2018 - 2030 (USD Million)
  • Table 12 North America Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 13 North America Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 14 North America Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 15 U.S. Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 16 U.S. Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 17 U.S. Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 18 Canada Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 19 Canada Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 20 Canada Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 21 Mexico Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 22 Mexico Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 23 Mexico Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 24 Europe Veterinary Oncology Market, by Country, 2018 - 2030 (USD Million)
  • Table 25 Europe Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 26 Europe Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 27 Europe Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 28 Germany Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 29 Germany Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 30 Germany Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 31 UK Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 32 UK Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 33 UK Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 34 France Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 35 France Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 36 France Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 37 Italy Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 38 Italy Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 39 Italy Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 40 Spain Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 41 Spain Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 42 Spain Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 43 Denmark Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 44 Denmark Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 45 Denmark Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 46 Sweden Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 47 Sweden Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 48 Sweden Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 49 Norway Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 50 Norway Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 51 Norway Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific Veterinary Oncology Market, by Country, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 56 China Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 57 China Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 58 China Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 59 Japan Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 60 Japan Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 61 Japan Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 62 India Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 63 India Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 64 India Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 65 South Korea Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 66 South Korea Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 67 South Korea Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 68 Australia Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 69 Australia Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 70 Australia Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 71 Thailand Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 72 Thailand Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 73 Thailand Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 74 Latin America Veterinary Oncology Market, by Country, 2018 - 2030 (USD Million)
  • Table 75 Latin America Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 76 Latin America Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 77 Latin America Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 78 Brazil Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 79 Brazil Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 80 Brazil Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 81 Argentina Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 82 Argentina Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 83 Argentina Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 84 Middle East & Africa Veterinary Oncology Market, by Country, 2018 - 2030 (USD Million)
  • Table 85 Middle East & Africa Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 86 Middle East & Africa Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 87 Middle East & Africa Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 88 South Africa Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 89 South Africa Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 90 South Africa Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 91 South Africa Veterinary Oncology Market, by End Use, 2018 - 2030 (USD Million)
  • Table 92 Saudi Arabia Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 93 Saudi Arabia Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 94 Saudi Arabia Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 95 UAE Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 96 UAE Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 97 UAE Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 98 Kuwait Veterinary Oncology Market, by Animal Type, 2018 - 2030 (USD Million)
  • Table 99 Kuwait Veterinary Oncology Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 100 Kuwait Veterinary Oncology Market, by Cancer Type, 2018 - 2030 (USD Million)
  • Table 101 Participants overview
  • Table 102 Financial performance
  • Table 103 Key market players pursuing approvals & clearances
  • Table 104 Key market players initiate mergers & acquisitions.
  • Table 105 Key market players initiate collaboration & partnerships.
  • Table 106 Key market players initiating product/ service launches/expansions
  • Table 107 Key market players undertaking R&D partnerships
  • Table 108 Key market players undertaking other activities.
  • Table 109 List of other key market players

List of Figures

  • Fig. 1 Veterinary oncology market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Data analysis models
  • Fig. 6 Market formulation and validation
  • Fig. 7 Data validation & publishing
  • Fig. 8 Volume x Price Analysis
  • Fig. 9 General methodology for commodity flow analysis of animal health market
  • Fig. 10 Commodity flow analysis
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Veterinary oncology market value, 2024 (USD Billion)
  • Fig. 16 Ancillary market outlook, 2024
  • Fig. 17 Veterinary oncology market dynamics
  • Fig. 18 Basic annual expenses for dog and cat owners in USD (2024)
  • Fig. 19 veterinary oncology market: PORTER's analysis
  • Fig. 20 veterinary oncology market: PESTEL analysis
  • Fig. 21 Estimated number of veterinary service establishments in the U.S., 2018 to 2030
  • Fig. 22 Veterinary oncology market by animal type: key takeaways
  • Fig. 23 Veterinary oncology market by animal type, Market share, 2023 & 2030
  • Fig. 24 Canine market, 2018 - 2030 (USD Million)
  • Fig. 25 Feline market, 2018 - 2030 (USD Million)
  • Fig. 26 Equine market, 2018 - 2030 (USD Million)
  • Fig. 27 Veterinary oncology market by therapy: key takeaways
  • Fig. 28 Veterinary oncology market by therapy, market share, 2024 & 2030
  • Fig. 29 Radiotherapy market, 2018 - 2030 (USD Million)
  • Fig. 30 Stereotactic radiation therapy market, 2018 - 2030 (USD Million)
  • Fig. 31 LINAC market, 2018 - 2030 (USD Million)
  • Fig. 32 Others market, 2018 - 2030 (USD Million)
  • Fig. 33 Conventional radiation therapy market, 2018 - 2030 (USD Million)
  • Fig. 34 Surgery market, 2018 - 2030 (USD Million)
  • Fig. 35 Chemotherapy market, 2018 - 2030 (USD Million)
  • Fig. 36 Immunotherapy market, 2018 - 2030 (USD Million)
  • Fig. 37 Other therapies market, 2018 - 2030 (USD Million)
  • Fig. 38 Veterinary oncology market by cancer type: Key takeaways
  • Fig. 39 Veterinary oncology market by cancer type, market share, 2024 & 2030
  • Fig. 40 Skin Cancers market, 2018 - 2030 (USD Million)
  • Fig. 41 Lymphomas market, 2018 - 2030 (USD Million)
  • Fig. 42 Sarcomas market, 2018 - 2030 (USD Million)
  • Fig. 43 Others market, 2018 - 2030 (USD Million)
  • Fig. 44 Veterinary oncology market revenue, by region, 2023 & 2030 (USD Million)
  • Fig. 45 Regional market share analysis, 2023 & 2030
  • Fig. 46 Regional marketplace: key takeaways
  • Fig. 47 Regional marketplace: key takeaways
  • Fig. 48 Regional marketplace: key takeaways
  • Fig. 49 North America veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 U.S. veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Canada veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Mexico veterinary oncology market, 2018 - 2030 (USD Million)
  • Fig. 56 Europe veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 UK. veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Germany veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 France veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Italy veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Spain veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Sweden veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Denmark veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Norway veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Rest of Europe veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Asia Pacific veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Japan veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 China veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 India veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 South Korea veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Australia veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Thailand veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Rest of Asia Pacific veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Latin America veterinary oncology market, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Brazil veterinary oncology market, 2018 - 2030 (USD Million)
  • Fig. 89 Argentina veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Rest of Latin America veterinary oncology market, 2018 - 2030 (USD Million)
  • Fig. 91 MEA veterinary oncology market, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 South Africa veterinary oncology market, 2018 - 2030 (USD Million)
  • Fig. 94 Saudi Arabia veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 UAE veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Kuwait veterinary oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Rest of MEA veterinary oncology market, 2018 - 2030 (USD Million)
  • Fig. 98 Market participant categorization
  • Fig. 99 Heat map analysis
  • Fig. 100 Key strategies deployed by market players